ONCY
ONCOLYTICS BIOTECH INCCompany Information
- Company Name
- ONCOLYTICS BIOTECH INC
- CIK
- CIK0001129928
- Category
- Non-accelerated filer<br>Smaller reporting company
- Ticker: Exchange
- ONCY: Nasdaq
- Fiscal Year End
- December 31
- Owner Organization
- 03 Life Sciences
- SIC
- 2834
- SIC Description
- Pharmaceutical Preparations
- Ticker
- ONCY
SEC filing data through
Insider Sentiment
- Last purchase
- 2026-03-12
- Last sale
- —
- Shares purchased (TTM)
- 338,682
- Shares sold (TTM)
- 0
Institutional Sentiment
- As of
- 2026-06-30
- Institutional shares owned
- 3,753,520
- Shares outstanding
- 119,739,942
- Ownership
- 3.13%
Earnings Market Reaction
- Filing date
- 2026-08-12
- Price on filing date
- —
- 1-month reaction
- 2.44%
- 3-month reaction
- …
Balance Sheet
Values in millions ($)| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Trend |
|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||
| Cash And Cash Equivalents At Carrying Value | 4 | 5 | 5 | ||||||
| Other Receivables Net Current | 1 | 1 | 1 | ||||||
| Prepaid Expense Current | 2 | 1 | 1 | ||||||
| Assets Current | 7 | 7 | 7 | ||||||
| Property Plant And Equipment Net | 0 | 0 | 0 | ||||||
| Operating Lease Right Of Use Asset | 0 | 0 | 1 | ||||||
| Assets | 8 | 8 | 8 | ||||||
Liabilities Current | |||||||||
| Accounts Payable Current | 3 | 3 | 4 | ||||||
| Accrued Liabilities Current | 2 | 3 | 2 | ||||||
| Other Liabilities Current | - | - | 0 | ||||||
| Operating Lease Liability Current | 0 | 0 | 0 | ||||||
| Derivative Liabilities Current | 0 | 0 | 0 | ||||||
| Liabilities Current | 5 | 5 | 6 | ||||||
| Contract With Customer Liability Noncurrent | 5 | 5 | 5 | ||||||
| Deferred Compensation Sharebased Arrangements Liability Classified Noncurrent | 3 | 3 | - | ||||||
| Operating Lease Liability Noncurrent | 0 | 0 | 0 | ||||||
| Liabilities | 14 | 13 | 11 | ||||||
Equity | |||||||||
| Common Stock Value | 0 | 0 | 0 | ||||||
| Additional Paid In Capital | 436 | 427 | 419 | ||||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | 6 | 6 | 6 | ||||||
| Retained Earnings Accumulated Deficit | -448 | -439 | -429 | ||||||
| Stockholders Equity | -6 | -5 | -4 | ||||||
| Liabilities And Stockholders Equity | 8 | 8 | 8 | ||||||
| Common Stock Par Or Stated Value Per Share | 0.00 | 0.00 | - | ||||||
| Common Stock Shares Authorized | 1,000 | 1,000 | - | ||||||
| Common Stock Shares Issued | 125 | 116 | 108 | ||||||
| Shares Outstanding | 125 | 116 | 108 | ||||||
Select a line item above to chart it.
Recent filings
Financial statements beyond 3 years are for subscribers only.
Unlock 17+ years of income statements, balance sheets, and cash flow statements
Start 7-day free trialONCOLYTICS BIOTECH INC (ONCY) — SEC Financial Statements & Analysis
ONCOLYTICS BIOTECH INC (ONCY) is a pharmaceutical preparations company, incorporated in NV. ONCOLYTICS BIOTECH INC trades on Nasdaq as: ONCY. ONCOLYTICS BIOTECH INC (ONCY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12. Based on that filing, ONCOLYTICS BIOTECH INC carries a market cap of $113.75M, a P/B ratio of -18.45x, and an enterprise value of $109.64M. On the balance sheet, it maintains a current ratio of 1.35x, a quick ratio of 1.02x, working capital of $1.84M, a debt-to-equity ratio of -2.24x, a debt ratio of 1.8, and net debt of $-4.12M. Figures sourced from SEC EDGAR.
- Market Cap
- $113.75M
- P/B TTM
- -18.45x
- Debt To Equity
- -2.24x
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is ONCOLYTICS BIOTECH INC in?
ONCOLYTICS BIOTECH INC (ONCY) operates in the Pharmaceutical Preparations industry.
What exchange does ONCY trade on?
ONCOLYTICS BIOTECH INC (ONCY) trades on the Nasdaq.
Where is ONCOLYTICS BIOTECH INC incorporated?
ONCOLYTICS BIOTECH INC is incorporated in NV.
When was ONCOLYTICS BIOTECH INC (ONCY)'s most recent SEC filing?
ONCOLYTICS BIOTECH INC (ONCY)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-12.
What is ONCY's market cap?
ONCOLYTICS BIOTECH INC (ONCY) has a market capitalization of $113.75M as of 2026-06-30.